Lecture Café: “Airway diseases in two worlds – from Belgium to China” – 19 February 2013 – Ghent
February 4, 2013 Category Activities by FCCC Structural Partners, Weekly
The second Lecture Café entitled: “Airway diseases in two worlds – from Belgium to China” by Prof. Dr. Claus Bachert and Prof. Dr. Zhang Nan (Faculty of Medicine and Health Sciences, Upper Airways Research Laboratory) will take place on Tuesday 19 February from 12:00 to 14.00 in KANTL (Koningstraat 18, Gent). A free sandwich meal will be provided. Subscribing is free of costs, but mandatory, via https://webapps.ugent.be/eventManager/events/LectureCafes
Upper airway diseases such as sinusitis have a prevalence of 11% nowadays, and can be differentiated in subgroups according to the individual type of inflammation. Although clinically similar, sinus disease in China does show a completely different inflammation compared to the European counterpart. From this difference, we can learn more about the role of inflammation in this disease. The presentation will cover the clinical and the immunological side of disease, and will give you an insight into management of airway disease today and tomorrow in two different worlds, Belgium and China.
Prof. Dr. Claus Bachert, professor at Ghent University Hospital, clinician and researcher in Rhinology (head of the Upper Airways Research Laboratory), is member of international initiatives on evidence-based medicine in upper airway disease and member of several European FP7 research programmes.
Zhang Nan, professor at Zhongshan People’s Hospital in China, was senior ENT surgeon and is now researcher at the Upper Airways Research Laboratory at Ghent University.
The Lecture Cafés are a joint initiative of the UGent China Platform, the India Platform and the International Office of the Faculty of Bioscience Engineering.
- KURT VANDEPUTTE (UMICORE) APPOINTED CHAIRMAN OF THE BOARD OF THE FLANDERS-CHINA CHAMBER OF COMMERCE (FCCC)
- Webinar: “Knowing Your Chinese Partner” – May 26, 2021, 10 am – 12 am
- EMA starts rolling review of CoronaVac, WHO approves Sinopharm vaccine for emergency use
- The Global Times warns not to politicize the Comprehensive Agreement on Investment (CAI)
- Hainan to become biggest duty-free market in the world